The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- Updated Pocket Guides for Treatment of Chronic HCV with Direct-Acting Antivirals Guideline (6/7/19)
- Updated Treatment of Chronic HCV with Direct-Acting Antivirals Guideline (5/24/19)
- Topics, Trends, and Updates (5/9/19)
- New: ART Drug-Drug Interactions Resource (4/25/19)
- Frequently Asked Questions about HIV Testing (3/19/19)
- Updated Pocket Guide to Selecting an Initial ART Regimen (2/5/19)
- Updated Selecting an Initial ART Regimen Guideline (1/28/19)
- New: When to Initiate ART Pocket Guide (12/21/18)
- AETC NCRC Quarterly Newsletter (6/14/19)
- AIDSinfo: Updates to the Microsporidiosis Section of the Adult and Adolescent Opportunistic Infections Guidelines (6/14/19)
- AETC NCRC Updates (6/4/19)
- AIDSinfo Updates Consumer Fact Sheets (5/23/19)
- AIDSinfo Releases Fact Sheet on Dovato, a New HIV Medication (5/9/19)
Final Results of the PARTNER 2 Study Confirm Undetectable = Untransmittable (U=U): Dr. Alison Rodger presented the final results of the PARTNER2 study at the 22nd International AIDS Conference in Amsterdam in July 2018. The findings of the study . . . Read more
Relative Contributions of Traditional Modifiable Risk Factors to Morbidity Among People with HIV: Compared with people who do not have HIV, people with HIV, even those with well-controlled disease, have an elevated risk of MI, ESLD, ESRD, and NADCs . . . Read more
- CEI Newsletter (6/18/19)
- NYS Medicaid Update (6/5/19)
- NYSDOH AIDS Institute Seeks Member Nominations for the New York State HIV Advisory Body (HAB) (5/16/19)
- NYSDOH AIDS Institute: New Minor Consent Booklet and Postcard: You Can Say Yes (5/15/19)
- Dear Colleague Letter: Availability of a Hepatitis C Quality of Care Assessment Tool: eHEPQUAL (5/7/19)
- 6/22/19: UCDOHMH: Buprenorphine Waiver Eligibility Training for Clinical Providers: Ulster County (Kingston, NY)
- 6/25/19: MATEC: Triple Treat II: HIV, HCV and Opioids (Chicago, IL)
- 6/26/19: SCDHS: Buprenorphine Waiver Eligibility Training for Clinical Providers: Suffolk County (Great River, NY)
- 6/28/19: CEI/Mount Sinai: Transgender and Non-Binary Healthcare: Best Practices and Clinical Updates (New York, NY)
- 6/29/19: OCHD: Buprenorphine Waiver Eligibility Training for Clinical Providers: Onondaga County (Syracuse, NY)
- 6/19/19: CEI This Month in HIV: Care Considerations for the Older Patient with HIV
- 6/19/19: SE AETC: Smoking Cessation in HIV
- 6/20/19: AETC NCRC: Models of Hepatitis C Care for People with Substance Use Disorders: Creating Treatment Champions
- 6/20/19: New York State Hepatitis C Elimination Plan Community Call
- 6/20/19: Empire Liver Foundation: Monitoring Prior, During and After Treatment